Cipla, India and Eli Lilly
Digest more
Novo Nordisk and Eli Lilly stocks fell after Trump announced Ozempic prices could drop to $150 monthly from $1,000.
Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...
Axios on MSN
How Eli Lilly became the new king of GLP-1s
Eli Lilly is poised to leapfrog Novo Nordisk and become the dominant player in an anti-obesity drug market that could reach ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results